Position history for Sculptor Capital LP's holdings in ImmunityBio, Inc.
Sculptor Capital LP holds 619,000 shares of IBRX (ImmunityBio, Inc.), worth $1.2M as of 2025-Q4. IBRX represents 0.0% of Sculptor Capital LP's portfolio.
Current Value
$1.2M
Current Shares
619,000
Total Value Change
-$203,874
Total Shares Change
+352,800
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 619,000 |
0.0% |
| $1.2M |
| 0.0% |
| $1.98 |
0 |
| 2025-Q3 | Increased | 619,000 | +100.6% | $1.5M | 0.0% | $2.57 | 41 |
| 2025-Q2 | New | 308,600 | - | $814,704 | 0.0% | $2.70 | 34 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $3.14 | 0 |
| 2024-Q4 | Increased | 270,800 | +24.3% | $693,248 | 0.0% | $2.68 | 30 |
| 2024-Q3 | Increased | 217,800 | +77.8% | $810,216 | 0.0% | $3.93 | 38 |
| 2024-Q2 | Decreased | 122,500 | -54.0% | $774,200 | 0.0% | $6.32 | 0 |
| 2024-Q1 | Increased | 266,200 | +234.8% | $1.4M | 0.0% | $5.37 | 41 |